About HizentraOverview of HizentraBenefits of HizentraSelf-AdministrationSelf-Administration VideoWhat to expectQuestions about HizentraStarting on HizentraAbout PIDDAssistance and SupportRequest More InformationImportant Safety Information

Self-Administration Video

Find out how to self-administer Hizentra at home or anywhere you have a clean, flat surface. Watch the Hizentra self-administration video below to learn the step-by-step instructions on preparation, proper infusion techniques, and administration.

Order your own DVD

Having a copy of the Hizentra self-administration video on DVD is a great way to learn how to self-administer, to refresh your technique, or to help a caregiver learn. Order the DVD now.

Download a step-by-step infusion guide

Download a copy of the step-by-step infusion guide that you can always refer to.

The Hizentra self-administration video and instructions are intended to support information already provided to you by a healthcare professional trained in the administration of Hizentra. It should be used in conjunction with the full Prescribing Information. Patients, caregivers, and clinicians are encouraged to read the product information thoroughly before administering Hizentra. Please note that the vast majority of people will require more than one training session before feeling ready and comfortable to self-administer Hizentra.

What can I expect with Hizentra?

In the US and EU studies, the majority of injection-site reactions with Hizentra were mild to moderate.

View side effects
Use this therapy journal to track your infusions

Important Safety Information

Immune Globulin Subcutaneous (Human), Hizentra®, treats various forms of primary immunodeficiency (PI) in patients age 2 and over.

Hizentra should not be used if you have had serious negative reactions to immune globulin (Ig) preparations or a deficiency of an Ig known as IgA. Because Hizentra contains the amino acid proline as stabilizer, patients with hyperprolinemia (too much proline in the blood) should not take Hizentra.

Infuse Hizentra under your skin only; do not inject into a blood vessel.

Allergic reactions can occur with Hizentra. If your doctor suspects you are having a bad allergic reaction or are going into shock, treatment will be discontinued. Immediately tell your doctor or go to the emergency room if you have signs of such a reaction, including hives, trouble breathing, wheezing, dizziness, or fainting.

Tell your doctor about any side effects that concern you. Your doctor will monitor for potentially serious reactions that have been seen with Ig treatment, including thrombotic events (blood clotting); aseptic meningitis syndrome (brain swelling); osmotic nephropathy (a kidney condition); hemolysis (a blood problem) and transfusion-related acute lung injury.

The most common drug-related adverse reactions in the clinical trial for Hizentra were injection-site reactions (swelling, pain, redness, heat or itching); headache; back pain; diarrhea; tiredness; cough; rash; itching; nausea and vomiting.

Hizentra is made from components of human blood. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.

Vaccines (such as measles, mumps and rubella) might not work as well if you are using Hizentra. Before receiving a vaccination, tell the healthcare professional that you are being treated with Hizentra. Also tell your doctor if you are pregnant or nursing, or if you plan to become pregnant.

Please see full prescribing information for Hizentra, including the patient product information.

You are encouraged to report negative effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.